entertainment -WSS

entertainment

author：entertainment 2025-08-11 11:46:06 - browse：59633

Illumina, the largest maker of DNA-sequencing technology and a storied name in the biotechnology industry, named Jacob Thaysen, a 10-year-veteran at life sciences-tools firm Agilent, as its new CEO.

The appointment follows a bitter board fight that ended with the departure of Francis deSouza, who had been Illumina’s CEO since 2016. The battle, tipped off by Illumina’s troubled acquisition of cancer diagnostics firm Grail, had involved a proxy fight staged by activist investor Carl Icahn.

During the battle, there had been speculation that Jay Flatley, deSouza’s predecessor, could return. Under Flatley, Illumina had grown from an upstart to the dominant player in a field that has proved pivotal for medical research and delivered sizable returns to investors.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Sarepta Duchenne therapy fails to meet primary endpoint in trial

WSS

Intellia reports positive results for its CRISPR

How neuroscience research could help beat back brain cancer

Bill would allow buprenorphine prescription for addiction via telehealth

See how much Covid

Coloradans with cystic fibrosis could lose access to Trikafta

Inari Medical to buy amputation prevention company LimFlow

entertainment

entertainment

leisure time

Walensky prepares to leave CDC — and Congress — behind

How to convince healthy people to buy insurance

Medicare details structure of new drug price negotiation program

Brain injuries and the importance of a second opinion

Psychedelics group wrestles with new pharma identity

FDA's Pazdur wants cancer trials to range beyond China alone

Activists slam private health insurers over coverage restrictions

How neuroscience research could help beat back brain cancer

After affirmative action ruling, medical educators look to 'holistic review'

ASCO: Palliative care found as helpful given virtually as in person

knowledge

At ASCO, AstraZeneca reports strong data for breast cancer drug

With trial win, GSK could get blood cancer drug back on market

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Woman returns to dialysis after doctors remove transplanted pig kidney

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

entertainment

entertainment

Wikipedia

explore